Online Only Articles

Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells

Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada;Institute of Medical Science, University of Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
Samuel Lunenfeld Research Institute, Toronto, ON, Canada
Samuel Lunenfeld Research Institute, Toronto, ON, Canada;Department of Agricultural, Food, and Environmental Sciences, University of Perugia, Italy
Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada;Department of Pharmacology and Toxicology, University of Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada;Institute of Medical Science, University of Toronto, ON, Canada
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada;Institute of Medical Science, University of Toronto, ON, Canada
Vol. 101 No. 11 (2016): November, 2016 https://doi.org/10.3324/haematol.2016.146894